Series stock is trading -8.46% below its average target price of $70.6 after dropping -11.5% during today's afternoon session. Analysts are giving the Large-Cap Scientific & Technical Instruments company an average rating of buy and target prices ranging from $59.0 to $78.0 per share.
The stock has an average amount of shares sold short at 5.3%, and a short ratio of 3.16. The company's insiders own 1.34% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 120.2% of Series's shares being owned by this investor type.
Institutions Invested in Series
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-03-31 | Capital International Investors | 19% | 11,757,066 | $759,859,143 |
| 2025-03-31 | Vanguard Group Inc | 9% | 5,546,191 | $358,450,309 |
| 2025-03-31 | T. Rowe Price Investment Management, Inc. | 7% | 4,530,367 | $292,797,606 |
| 2025-03-31 | FMR, LLC | 7% | 4,485,752 | $289,914,139 |
| 2025-03-31 | JPMORGAN CHASE & CO | 7% | 4,473,990 | $289,153,961 |
| 2024-12-31 | NORGES BANK | 6% | 3,485,746 | $225,283,754 |
| 2025-03-31 | Janus Henderson Group PLC | 5% | 3,037,594 | $196,319,691 |
| 2025-03-31 | Capital Research Global Investors | 3% | 2,027,090 | $131,010,821 |
| 2025-06-30 | Bessemer Group, Inc. | 3% | 1,889,787 | $122,136,928 |
| 2025-03-31 | Blackrock Inc. | 3% | 1,677,046 | $108,387,478 |
Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on Series.
